← Back to Search

Home Exercise Program for Heart Condition

N/A
Recruiting
Led By Jesse Hansen, MD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up day 1 (baseline), week 26 (final visit)
Awards & highlights
No Placebo-Only Group

Summary

This trial tests a home exercise program using telemedicine for people with a specific heart condition called Fontan physiology. The goal is to improve their fitness and reduce barriers to accessing exercise programs. Participants will get online support to help them stay active. Exercise training has been shown to increase exercise capacity in survivors of Fontan surgery.

Who is the study for?
This trial is for adults with Fontan heart physiology who can exercise and aren't on IV heart drugs. It's not for those with severe heart issues seen in recent echocardiograms, under 130 cm tall, pregnant or planning pregnancy during the study, or have noncardiac conditions that could affect participation.
What is being tested?
The trial tests a home exercise program delivered via telemedicine to see if it improves frailty and exercise capacity in people with Fontan physiology. It also examines whether this approach overcomes barriers to access and affects liver disease markers associated with Fontan.
What are the potential side effects?
Since the intervention involves an exercise program, potential side effects may include typical workout-related discomforts such as muscle soreness or fatigue. However, specific risks related to individuals' pre-existing health conditions will be monitored.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~day 1 (baseline), week 26 (final visit)
This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1 (baseline), week 26 (final visit) for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in Frailty score by the Fried frailty instrument
Secondary study objectives
Change in Alanine Aminotransferase (ALT)
Change in Aspartate Transferase (AST)
Fibrosis
+7 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Home exercise programExperimental Treatment1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Home exercise program
2017
Completed Phase 3
~870

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.
Mechanism Of Action
Side Effect Profile
Prior Approvals
Other Research
Common treatments for frailty, such as structured exercise programs, work primarily by improving muscle strength, cardiovascular health, and overall physical function. These programs often include aerobic exercises, resistance training, and flexibility exercises. The mechanisms of action include enhanced muscle protein synthesis, increased blood flow, and improved metabolic function. For frailty patients, these improvements are crucial as they lead to better mobility, reduced risk of falls, and enhanced ability to perform daily activities. In the context of a telemedicine-based structured home exercise program, these benefits are particularly significant as they provide accessible, consistent, and guided physical activity, which can help overcome barriers related to socioeconomic and geographic factors. Additionally, improved overall health and circulation may positively impact markers of associated conditions, such as liver disease.
Adverse events and safety issues associated with physical activity and exercise for adults with osteoporosis and osteopenia: A systematic review of observational studies and an updated review of interventional studies.

Find a Location

Who is running the clinical trial?

University of MichiganLead Sponsor
1,855 Previous Clinical Trials
6,435,008 Total Patients Enrolled
3 Trials studying Frailty
80 Patients Enrolled for Frailty
Jesse Hansen, MDPrincipal InvestigatorUniversity of Michigan
1 Previous Clinical Trials
30 Total Patients Enrolled
1 Trials studying Frailty
30 Patients Enrolled for Frailty

Media Library

Home exercise program Clinical Trial Eligibility Overview. Trial Name: NCT05543733 — N/A
Frailty Research Study Groups: Home exercise program
Frailty Clinical Trial 2023: Home exercise program Highlights & Side Effects. Trial Name: NCT05543733 — N/A
Home exercise program 2023 Treatment Timeline for Medical Study. Trial Name: NCT05543733 — N/A
~17 spots leftby Oct 2025